Barclays Downgrades DBV Technologies S.A (DBVT) to Equalweight

Barclays analyst Geoff Meacham downgraded DBV Technologies S.A (NASDAQ: DBVT) from Overweight to Equalweight with a price target of $8.00 (from $30.00).

The analyst steps to the sideline citing increased risk for Viaskin technology and market opportunity. He lowers his outlook for the program to an Opex loss of EUR$220 million ( from a loss of EUR$211 million.)

For an analyst ratings summary and ratings history on DBV Technologies S.A click here. For more ratings news on DBV Technologies S.A click here.

Shares of DBV Technologies S.A closed at $14.15 yesterday.

You May Also Be Interested In

• Bernstein SocGen Group Upgrades Analog Devices (ADI) to Outperform
• Keysight Technologies (KEYS) PT Raised to $440 at UBS Amid Broad-Based AI Strength
• BofA Securities Upgrades Moderna (MRNA) to Neutral